Cas:367501-04-0 4-(4-Fluoro-2-methoxyphenoxy)piperidine manufacturer & supplier

We serve Chemical Name:4-(4-Fluoro-2-methoxyphenoxy)piperidine CAS:367501-04-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-(4-Fluoro-2-methoxyphenoxy)piperidine

Chemical Name:4-(4-Fluoro-2-methoxyphenoxy)piperidine
CAS.NO:367501-04-0
Synonyms:4-(4-Fluoro-2-methoxyphenoxy)piperidine
Molecular Formula:C12H16FNO2
Molecular Weight:225.25900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:307.636ºC at 760 mmHg
Density:1.125g/cm3
Index of Refraction:1.505
PSA:30.49000
Exact Mass:225.11700
LogP:2.29390

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-(4-Fluoro-2-methoxyphenoxy)piperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(4-Fluoro-2-methoxyphenoxy)piperidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(4-Fluoro-2-methoxyphenoxy)piperidine Use and application,4-(4-Fluoro-2-methoxyphenoxy)piperidine technical grade,usp/ep/jp grade.


Related News: About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. L-leucyl-L-leucyl-L-valyl-L-glutaminyl-L-asparaginyl-L-alanyl-L-asparaginyl-L-prolyl-L-aspartic acid manufacturers While Stevanato has been in the headlines for its involvement in the fight against Covid-19—its factories immediately sprang to work producing vials and syringes for vaccines when Italy was still under lockdown in April 2020—vaccines only made up 4% of the company’s revenues in 2020 and 2019. (R)-1-(phosphonooxy)butan-2-yl (3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl)carbamate suppliers In 2018, the Bengaluru-based Natural Capsules set up an R&D centre in at Attibele, Bengaluru. In 2020, when PLI scheme was announced it applied for the same. 1H-Imidazole, 2,2′-dithiobis[1-heptyl-4-methyl- vendor & factory.